Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study

2015; Elsevier BV; Volume: 16; Issue: 15 Linguagem: Inglês

10.1016/s1470-2045(15)00207-7

ISSN

1474-5488

Autores

Elias Jabbour, Hagop M. Kantarjian, Farhad Ravandi, Deborah A. Thomas, Xuelin Huang, Stefan Faderl, Naveen Pemmaraju, Naval Daver, Guillermo Garcia‐Manero, Koji Sasaki, Jorge E. Cortés, Rebecca Garris, C. Cameron Yin, Joseph D. Khoury, Jeffrey L. Jorgensen, Zeev Estrov, Zachary S. Bohannan, Marina Konopleva, Tapan M. Kadia, Nitin Jain, Courtney D. DiNardo, William G. Wierda, Vicky Jeanis, Susan O’Brien,

Tópico(s)

Eosinophilic Disorders and Syndromes

Referência(s)